MedPath

Brief behavioral therapeutic intervention for reducing depersonalization during exams in test anxiety

Phase 2
Conditions
Depersonalisation in test anxiety
F40.2
Specific (isolated) phobias
Registration Number
DRKS00010190
Lead Sponsor
Technische Universität Dresden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Test anxiety (cut-off percentile ranks > 75 in test anxiety questionnaire; Hodapp, Rohrmann, & Ringeisen, 2011), min. 1 Item in the retrospective survey for the last exam with the adapted version of the German Cambridge Depersonalization Scale (Hoyer, Braeuer, Crawcour, Klumbies, & Kirschbaum, 2013) in the field of high intensity (> 66) and an average value of min. 20 in the scale, the depersonalization during examination situations is experienced as unpleasant, annoying or alienating (newly created items)

Exclusion Criteria

dissociative disorder, addictive disorders (except nicotine) , psychotic disorder, Borderline personality disorder, post-traumatic stress disorder, severe depressive episode, heart disease, epilepsy, migraine, pregnancy, current psychotherapeutic or psychiatric treatment, average consumption of more than 10 cigarettes per day

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Significant difference between the intervention and of the waitlist control group in the reported severity of experienced depersonalization during the Trier Social Stress Test for groups (TSST-G; von Dawans, Kirschbaum, & Heinrichs, 2011), measured with the adapted version of the German Cambridge Depersonalization Scale (original: Sierra, 2000; German version: adapted version: Michal et al, 2004; Hoyer, Braeuer, Crawcour, Klumbies, & Kirschbaum 2013) directly after the TSST-G.
Secondary Outcome Measures
NameTimeMethod
Significant difference between the intervention and of the waitlist control group in the situational cognitive assessment at the beginning of the Trier Social Stress Test in groups (TSST-G; von Dawans, Kirschbaum, & Heinrichs, 2011), as measured by the Primary appraisal Secondary-Appraisal Questionnaire (Gaab et al, 2005), in the heart rate variability during the performance of TSST-G and the reported level of experienced anxiety, measured with the state scale of the State-Trait anxiety inventory (German version: Laux, Glanzmann, Schaffner, & Spielberger, 1981) immediately after the TSST-G.
© Copyright 2025. All Rights Reserved by MedPath